Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boerries Brandenburg

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Hepatology (Baltimore, Md.)|December 1, 2005
A novel system for efficient gene transfer into primary human hepatocytes via cell-permeable hepatitis B virus-like particleBoerries Brandenburg, Lars Stockl, Cindy Gutzeit, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle levelJason J Otterstrom, Boerries Brandenburg, Martin H Koldijk, et al.
Vaccines|January 8, 2025
Plant Cell Culture-Derived Saponin Adjuvant Enhances Immune Response Against a Stabilized Human Metapneumovirus Pre-Fusion Vaccine CandidateMaarten Swart, Jessica Allen, Brendan Reed, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2022
Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regionsFin J Milder, Mandy Jongeneelen, Tina Ritschel, et al.
Plos One|December 19, 2013
Mechanisms of hemagglutinin targeted influenza virus neutralizationBoerries Brandenburg, Wouter Koudstaal, Jaap Goudsmit, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2025
De novo design of D-peptide ligands: Application to influenza virus hemagglutininJarek Juraszek, Rameshwar U Kadam, Davide Branduardi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2026
Small molecule-constrained paratope mimetic bicyclic peptides as potent inhibitors of group 1 and 2 influenza A virus hemagglutininsRameshwar U Kadam, Jarek Juraszek, Boerries Brandenburg, et al.
Nature Communications|April 13, 2026
A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a studyNina Hertoghs, Chan Tang, Vitalija van Paassen, et al.
Frontiers in Immunology|October 18, 2016
HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic AcidsFreek Cox, Ted Kwaks, Boerries Brandenburg, et al.
Npj Viruses|December 18, 2025
V<sub>H</sub>H antibody loop guides design of a synthetic macrocyclic peptide that potently blocks influenza virus membrane fusionRameshwar U Kadam, Jarek Juraszek, Boerries Brandenburg, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|December 1, 2005
A novel system for efficient gene transfer into primary human hepatocytes via cell-permeable hepatitis B virus-like particleBoerries Brandenburg, Lars Stockl, Cindy Gutzeit, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle levelJason J Otterstrom, Boerries Brandenburg, Martin H Koldijk, et al.
Vaccines|January 8, 2025
Plant Cell Culture-Derived Saponin Adjuvant Enhances Immune Response Against a Stabilized Human Metapneumovirus Pre-Fusion Vaccine CandidateMaarten Swart, Jessica Allen, Brendan Reed, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2022
Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regionsFin J Milder, Mandy Jongeneelen, Tina Ritschel, et al.
Plos One|December 19, 2013
Mechanisms of hemagglutinin targeted influenza virus neutralizationBoerries Brandenburg, Wouter Koudstaal, Jaap Goudsmit, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2025
De novo design of D-peptide ligands: Application to influenza virus hemagglutininJarek Juraszek, Rameshwar U Kadam, Davide Branduardi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2026
Small molecule-constrained paratope mimetic bicyclic peptides as potent inhibitors of group 1 and 2 influenza A virus hemagglutininsRameshwar U Kadam, Jarek Juraszek, Boerries Brandenburg, et al.
Nature Communications|April 13, 2026
A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a studyNina Hertoghs, Chan Tang, Vitalija van Paassen, et al.
Frontiers in Immunology|October 18, 2016
HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic AcidsFreek Cox, Ted Kwaks, Boerries Brandenburg, et al.
Npj Viruses|December 18, 2025
V<sub>H</sub>H antibody loop guides design of a synthetic macrocyclic peptide that potently blocks influenza virus membrane fusionRameshwar U Kadam, Jarek Juraszek, Boerries Brandenburg, et al.
Pageof 4